Formula Pharmaceuticals Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Formula Pharmaceuticals General Information
Description
Developer of chimeric antigen receptor immunotherapies designed for critical unmet medical needs in cancer. The company offers leverage on an allogeneic source, non-viral transfection, and a differentiated immune effector cell, called cytokine-induced killer cells, for developing cancer immunotherapies.
Contact Information
Website
www.formulapharma.comCorporate Office
- 1055 Westlakes Drive
- Suite 300
- Berwyn, PA 19312
- United States
Corporate Office
- 1055 Westlakes Drive
- Suite 300
- Berwyn, PA 19312
- United States
Formula Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Formula Pharmaceuticals Comparisons
Industry
Financing
Details
Formula Pharmaceuticals Competitors (7)
One of Formula Pharmaceuticals’s 7 competitors is Immuto Scientific, a Venture Capital-Backed company based in Cambridge, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Immuto Scientific | Venture Capital-Backed | Cambridge, MA | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| Bristol-Myers Squibb | Corporation | Princeton, NJ | ||||
| Exact Sciences | Formerly VC-backed | Madison, WI | ||||
| Vicore Pharma Holding | Formerly VC-backed | Stockholm, Sweden |
Formula Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Formula Pharmaceuticals Investments (1)
Formula Pharmaceuticals’s most recent deal was a Corporate Asset Purchase with Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform. The deal was made on 11-May-2015.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Non-Viral Chimeric Antigen Receptor (CAR) Immunotherapy Platform | 11-May-2015 | Corporate Asset Purchase | Buildings and Property |
Formula Pharmaceuticals FAQs
-
When was Formula Pharmaceuticals founded?
Formula Pharmaceuticals was founded in 2009.
-
Where is Formula Pharmaceuticals headquartered?
Formula Pharmaceuticals is headquartered in Berwyn, PA.
-
What industry is Formula Pharmaceuticals in?
Formula Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Formula Pharmaceuticals a private or public company?
Formula Pharmaceuticals is a Private company.
-
What is Formula Pharmaceuticals’s current revenue?
The current revenue for Formula Pharmaceuticals is .
-
Who are Formula Pharmaceuticals’s investors?
PIPV Capital has invested in Formula Pharmaceuticals.
-
Who are Formula Pharmaceuticals’s competitors?
Immuto Scientific, Ability Pharma, Bristol-Myers Squibb, Exact Sciences, and Vicore Pharma Holding are some of the 7 competitors of Formula Pharmaceuticals.
-
When was Formula Pharmaceuticals acquired?
Formula Pharmaceuticals was acquired on 16-Jan-2020.
-
Who acquired Formula Pharmaceuticals?
Formula Pharmaceuticals was acquired by Argos Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process